CO 048: ANTI-HYPERALGESIC EFFECT OF A NEUROPROTECTIVE COMPOUND IN ANIMAL MODELS OF PAIN

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S26, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 048: ANTI-HYPERALGESIC EFFECT OF A NEUROPROTECTIVE COMPOUND IN ANIMAL MODELS OF PAIN Castro M, Garrido-Suárez B, Pardo-Ruiz Z, Alcantara Y, Iglesias L, Merino N, Valdés O, Delgado R. Center of Research and Drug Development, Ave 26, … Continue reading CO 048: ANTI-HYPERALGESIC EFFECT OF A NEUROPROTECTIVE COMPOUND IN ANIMAL MODELS OF PAIN

J Pharm Pharmacogn Res 2(Suppl. 1): S26, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 048: ANTI-HYPERALGESIC EFFECT OF A NEUROPROTECTIVE COMPOUND IN ANIMAL MODELS OF PAIN

Castro M, Garrido-Suárez B, Pardo-Ruiz Z, Alcantara Y, Iglesias L, Merino N, Valdés O, Delgado R.

Center of Research and Drug Development, Ave 26, No. 1605 Boyeros y Puentes Grandes, CP 10600, Plaza de la Revolucion, La Habana, Cuba. E-mail: cidem@infomed.sld.cu
Abstract

Introduction: Chronic pain has been estimated to affect 8% of population. However it doesn´t exist an effective treatment for these pathologic phenomena, for this reason, new pharmacologic strategies have emerged to release chronic pain.

Aim: In the present study we evaluate the antihyperalgesic effect of systemic administration of a novel neuroprotective compound (NP1) in animal models of chronic pain with inflammatory and neuropathic components.

Methods: Nociceptive responding, indicated by licking/biting the affected hindlimb, was quantified during 45 min after formalin injection (5%) and mechanical allodynia was measured with von Frey filaments in chronic constriction injury (CCI). In CCI model was also determined nitric oxide concentration in sciatic nerve and in lumbar spinal cord, and was analysed qualitative changes in the histology of sciatic nerve.

Results: NP1 (10-40 mg/kg, p.o.) was effective in attenuating only the acute phase (phase II) of the formalin licking/biting response, dependending the dosis. Benzodiazepine antagonist flumazenil (10 mg/kg i.p.) partially reversed this effect. Its oral administration during 7 days in CCI model augmented the mechanical response thresholds (g) respect with CCI-vehicle group and increased nitric oxide concentration in spinal cord, but not in sciatic nerve. Histologically, it was found that NP1 has a neuroprotective action against Wallerian degeneration in CCI model, which includes less macrophage infiltration, number of digestion chambers and axonal degradation.

Conclusions: Because of this we can conclude that NP1 shows an antihyperalgesic effect in formalin test it could be related with his actions into GABAA/BDZ receptor, and it also has an antiallodynic and neuroprotective action in CCI model, which could be mediated by L-Arginine-NO-GMPc pathway.

Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 972-993, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1956_12.5.972 Original Article Anti-inflammatory effect of the mixture of Ageratum conyzoides L. extract and eggshell membrane hydrolysates and in silico active compound predictions [Efecto antiinflamatorio de la mezcla de extracto de Ageratum conyzoides L. e hidrolizados de membrana de cáscara de huevo, … Continue reading Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
SS-31 for diabetic nephropathy
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 956-971, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1904_12.5.956 Review SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies [El SS-31 protege la progresión de la nefropatía diabética: Una revisión sistemática de estudios in vivo e in vitro] Jonathan Christianto Sutadji1#, Dian Anggraini Permatasari … Continue reading SS-31 for diabetic nephropathy
Hypertension knowledge and its associated factors in primary care
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 943-955, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1955_12.5.943 Original Article Hypertension knowledge and its associated factors among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study [Conocimiento de la hipertensión y sus factores asociados entre pacientes hipertensos en entornos de atención primaria en el centro de … Continue reading Hypertension knowledge and its associated factors in primary care

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio